Atrium Therapeutics (RNA) Q1 2023 Earnings

23MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.93
-0.87
-0.8
-0.74

Details

Expected EPS
-0.85
Actual EPS
-0.74
Surprise EPS
0.11
Surprise Percent
+12.94%

Description

Atrium Therapeutics (RNA) has reported earnings of -0.74 per share for Q1 2023.

0 Comments

Share your thoughts